Mometasone sinus sinuva
Products billed under this code include Sinuva.
Payment limit per 10 MCG, by effective quarter, 2Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Sinuva.
Payment limit per 10 MCG, by effective quarter, 2Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Sinuva | Intersect ENT, INC. | 10599-0003-01 | 135 | $1,531.575 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $11.345 | $0.00 | 10 MCG | Mometasone sinus sinuva | v1, posted September 17, 2026 |
| 3Q26 | $11.345 | $0.00 | 10 MCG | Mometasone sinus sinuva | v1, posted September 15, 2026 |
| 2Q26 | $11.345 | $0.00 | 10 MCG | Mometasone sinus sinuva | v1, posted September 15, 2026 |
| 1Q26 | $11.345 | $0.00 | 10 MCG | Mometasone sinus sinuva | v1, posted September 15, 2026 |
| 4Q25 | $11.345 | $0.00 | 10 MCG | Mometasone sinus sinuva | v1, posted September 8, 2026 |
| 3Q25 | $11.345 | $0.00 | 10 MCG | Mometasone sinus sinuva | v1, posted March 10, 2026 |
| 2Q25 | $11.345 | $0.00 | 10 MCG | Mometasone sinus sinuva | v1, posted March 10, 2026 |
| 1Q25 | $11.345 | $0.00 | 10 MCG | Mometasone sinus sinuva | v1, posted December 19, 2025 |
| 4Q24 | $11.345 | $0.00 | 10 MCG | Mometasone sinus sinuva | v1, posted June 11, 2025 |
| 3Q24 | $11.345 | $0.00 | 10 MCG | Mometasone sinus sinuva | v1, posted June 11, 2025 |
| 2Q24 | $11.345 | $0.00 | 10 MCG | Mometasone sinus sinuva | v1, posted March 11, 2025 |
| 1Q24 | $11.345 | $0.00 | 10 MCG | Mometasone sinus sinuva | v1, posted December 19, 2024 |
| 4Q23 | $11.345 | $0.00 | 10 MCG | Mometasone sinus sinuva | v1, posted October 10, 2024 |
| 3Q23 | $11.345 | $0.00 | 10 MCG | Mometasone sinus sinuva | v1, posted June 5, 2024 |
| 2Q23 | $11.345 | $0.00 | 10 MCG | Mometasone sinus sinuva | v1, posted February 23, 2024 |
| 1Q23 | $11.345 | +$0.415 | 10 MCG | Mometasone sinus sinuva | v1, posted December 6, 2023 |
| 4Q22 | $10.93 | $0.00 | 10 MCG | Mometasone sinus sinuva | v1, posted June 22, 2023 |
| 3Q22 | $10.93 | +$0.37 | 10 MCG | Mometasone sinus sinuva | v1, posted June 9, 2023 |
| 2Q22 | $10.56 | $0.00 | 10 MCG | Mometasone sinus sinuva | v1, posted December 14, 2022 |
| 1Q22 | $10.56 | $0.00 | 10 MCG | Mometasone sinus sinuva | v1, posted June 8, 2022 |
| 4Q21 | $10.56 | $0.00 | 10 MCG | Mometasone sinus sinuva | v1, posted June 2, 2022 |
| 3Q21 | $10.56 | +$0.308 | 10 MCG | Mometasone sinus sinuva | v1, posted June 2, 2022 |
| 2Q21 | $10.252 | – | 10 MCG | Mometasone sinus sinuva | v1, posted March 1, 2022 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.